Yields of clear, evidence-based public health guidance have been similarly sparse for research on many other natural products (NP). With the goal of facilitating the development of such guidance by increasing the application of good practices to the foundational research, this topic expands on a 2019 review (1). The papers in this collection delve deeper into ways to increase the replicability, and thus also the public health-relevant yields from NP research across the spectrum from chemical characterization to clinical trials.Increased clarity on which components within a chemically complex NP participate in modulating specific biological outcomes should increase the information gained from clinical trials of these products. A related question is "how much of each key chemical reaches the in vivo site of action?" Aspects of this include product stability and replicability, bioavailability and metabolism. Optimization of methods for biochemical characterization and standardization of chemically complex NP are described in this topic by Abraham and Kellogg, Coskun et al., Floyd et al., and Lyu et Floyd et al., Weaver and Hodges and Wright et al. note the challenge and importance of evaluating absorption and pharmacokinetics for chemically complex products. Heterogeneity -genetic, epigenetic, dietary, etc, among humans, as well as between species -may alter product metabolic rates and the formation of biologically active metabolites(2). Chilton et al demonstrate the application of several approaches to detect human genetic variants which critically modify metabolic flux and the health effects of food (or other NP), with implications for optimizing clinical trial inclusionary criteria and interpretations.Floyd et al. describe the challenges of designing pre-clinical studies appropriately for translation to human studies. They highlight the importance of selecting the optimal animal models and dosing regimens for the outcomes of interest and for relevance to the population(s) of interest, and note the importance of considering potential sex differences. Weaver and Hodges note that while stringent inclusionary criteria may decrease the sample size required to provide a reasonable likelihood of avoiding a false positive or false negative result, greater inclusivity may allow greater generalizability. Floyd et al. add that other factors such as circadian rhythm and diet should be documented if not controlled, since they may strongly modulate pharmacokinetics.Moving further towards translation, issues of safety, optimal dosing regimen, tolerability, ability to mask the intervention in controlled trials, optimal trial population(s) and outcome(s), and regulatory compliance are all critical. Clinical researchers must consider the possibility of "floor effects" for ingredients present in the diet (3), and of "drop in" for supplements available over the counter.Weaver and Hodges adapted general best practices guidelines for human nutrition randomized controlled trials (4) specifically to plant-based interventions. Both Funk and Schneider and Weaver and Hodges note that while clinical trials are the gold standard for testing efficacy and providing evidence of causality, they should be undertaken only where they address a novel question of substantial public health significance.Funk and Schneider note that clinical trials based on traditional uses may be less likely to succeed where the effect of interest is more likely to respond to a placebo, and that translation of ethnobotanical research may be complicated by cultural differences in symptomatology as well as in other behaviors or even pharmacogenetics.Wright et al. provide a description of the development of a clinical trial-ready botanical product which meets requirements for toxic contaminants, is comparable in chemistry and dosing to the preclinical research and traditional products, minimizes participant burden (critical for recruitment, retention and compliance), and provides a good match to the placebo control.Weaver and Hodges note the importance of compliance with regulatory requirements, including those for data integrity and participant privacy and safety. Transparency must be ensured through pre-study registration of the trial protocol including the statistical analysis plan. A CONSORT (Consolidated Statement on Reporting (Clinical) Trials) checklist provides guidance for reporting herbal interventions (5). Equally essential for transparency, these authors describe the importance of thorough reporting and FAIR (Findable, Accessible, Interoperable, Replicable) data for the advancement of knowledge, as well as for compliance with requirements of funding agencies.Full adoption of the best practices described by authors in this topic will both increase the value of knowledge gained from translational research using chemically complex NP and increase the utility of NP clinical trial results for improving our understanding of NP effects on human health. Adoption of these practices will provide a more solid foundation for building the evidence base for the use of NP for health. *November 25, 2020 through November 24, 2021
7 Authors
- WL
Weiting Lyu
New Use Agriculture and Natural Plant Products Program, Department of Plant Biology and Center for Agricultural Food Ecosystems, Institute of Food, Nutrition & Health, Rutgers University, United States
- DR
David Rodriguez
Independent Researcher, United States
- MG
Mario G. Ferruzzi
Department of Food, Bioprocessing and Nutrition Sciences, Plants for Human Health Institute, North Carolina State University, United States
- GM
Giulio M. Pasinetti
Department of Neurology, Icahn School of Medicine at Mount Sinai, United States
- JW
James W. Murrough
Department of Neurology, Icahn School of Medicine at Mount Sinai, United States
- JE
James E. Simon
New Use Agriculture and Natural Plant Products Program, Department of Plant Biology and Center for Agricultural Food Ecosystems, Institute of Food, Nutrition & Health, Rutgers University, United States
- QW
Qingli Wu
New Use Agriculture and Natural Plant Products Program, Department of Plant Biology and Center for Agricultural Food Ecosystems, Institute of Food, Nutrition & Health, Rutgers University, United States
6,391 views
14 citations
3 Authors
- MD
Michael D. McAlpine
Department of Kinesiology, Faculty of Applied Health Sciences, Brock University, Canada
- JL
Jenalyn L. Yumol
Department of Kinesiology, Faculty of Applied Health Sciences, Brock University, Canada
- WE
Wendy E. Ward
Department of Kinesiology, Faculty of Applied Health Sciences, Brock University, Canada
4,940 views
5 citations
10 Authors
- WL
Weiting Lyu
New Use Agriculture and Natural Plant Products Program, Department of Plant Biology and Center for Agriculture and Food Ecosystems, Institute of Food, Nutrition & Health, Rutgers University, United States
- TO
Thamer Omar
Center for Structured Organic Particulate Systems, Chemical and Biochemical Engineering, Rutgers University, United States
- HP
Harna Patel
New Use Agriculture and Natural Plant Products Program, Department of Plant Biology and Center for Agriculture and Food Ecosystems, Institute of Food, Nutrition & Health, Rutgers University, United States
- DR
David Rodriguez
Eagle Nutritionals, United States
- MG
Mario G. Ferruzzi
Department of Food, Bioprocessing and Nutrition Sciences, Plants for Human Health Institute, North Carolina State University, United States
- GM
Giulio M. Pasinetti
Department of Neurology, Mount Sinai School of Medicine, United States
- JW
James W. Murrough
Geriatric Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, United States
- FJ
Fernando J. Muzzio
Center for Structured Organic Particulate Systems, Chemical and Biochemical Engineering, Rutgers University, United States
- JE
James E. Simon
New Use Agriculture and Natural Plant Products Program, Department of Plant Biology and Center for Agriculture and Food Ecosystems, Institute of Food, Nutrition & Health, Rutgers University, United States
- QW
Qingli Wu
New Use Agriculture and Natural Plant Products Program, Department of Plant Biology and Center for Agriculture and Food Ecosystems, Institute of Food, Nutrition & Health, Rutgers University, United States
8,818 views
9 citations


